<code id='0AD864BD93'></code><style id='0AD864BD93'></style>
    • <acronym id='0AD864BD93'></acronym>
      <center id='0AD864BD93'><center id='0AD864BD93'><tfoot id='0AD864BD93'></tfoot></center><abbr id='0AD864BD93'><dir id='0AD864BD93'><tfoot id='0AD864BD93'></tfoot><noframes id='0AD864BD93'>

    • <optgroup id='0AD864BD93'><strike id='0AD864BD93'><sup id='0AD864BD93'></sup></strike><code id='0AD864BD93'></code></optgroup>
        1. <b id='0AD864BD93'><label id='0AD864BD93'><select id='0AD864BD93'><dt id='0AD864BD93'><span id='0AD864BD93'></span></dt></select></label></b><u id='0AD864BD93'></u>
          <i id='0AD864BD93'><strike id='0AD864BD93'><tt id='0AD864BD93'><pre id='0AD864BD93'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:99

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Amazon on where the company's health care bets are headed next
          Amazon on where the company's health care bets are headed next

          AdobeThegraveyardislitteredwithAmazon’sbetsinhealthcare:wearables,Care,theill-fatedHaven.Outoftheira

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          How to fix cancer clinical trials' diversity problem

          Clockwisefromtopleft:STAT'sNicholasSt.Fleur(moderator);JudySewards,headofclinicaltrialexperienceatPf